Publication | Closed Access

Antitumor activities and schedule dependence of orally administered MST-16, a novel derivative of bis(2,6-dioxopiperazine)

Medicinal ChemistrySchedule DependenceMedicinePharmacologyPharmacotherapyAnti-cancer AgentDrug DevelopmentOncologyRadiation OncologyNovel DerivativeAntitumor ActivitiesDrug Discovery